NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs061230041

Registered date:02/08/2023

Effects of hydrogen jelly on depressive symptoms and cognitive function

Basic Information

Recruitment status Not Recruiting
Health condition(s) or Problem(s) studiedMild cognitive impairment, Depression in the elderly
Date of first enrollment05/08/2023
Target sample size70
Countries of recruitment
Study typeInterventional
Intervention(s)Hydrogen-containing jelly group: Hydrogen-containing jelly is swallowed without chewing three times a day (morning, noon, night) for 28 consecutive days. Hydrogen-free jelly (placebo) group: Hydrogen-free jelly (placebo) is swallowed without chewing three times a day (morning, noon, night) for 28 consecutive days.

Outcome(s)

Primary OutcomeSelf-administered questionnaire on depressive symptoms (Beck Depression Inventory: BDI, Patient Health Questionnaire-9: PHQ-9), cognitive function test by interview (Montreal Cognitive Assessment: MoCA-J)
Secondary OutcomeStress assessment by voice reading (Mind Monitoring System: MIMOSIS)

Key inclusion & exclusion criteria

Age minimum>= 70age old
Age maximumNot applicable
GenderBoth
Include criteriaPersons over 70 years old
Exclude criteria1. Persons who drink hydrogen water regularly 2. Persons who have gelatin allergy 3. Persons who have difficulty in swallowing

Related Information

Contact

Public contact
Name Maruyama Takayuki
Address 2-5-1, Shikata-cho, Kita-ku, Okayama Okayama Japan 700-8558
Telephone +81-86-235-6712
E-mail t-maru@md.okayama-u.ac.jp
Affiliation Okayama University Hospital
Scientific contact
Name Maruyama Takayuki
Address 2-5-1, Shikata-cho, Kita-ku, Okayama Okayama Japan 700-8558
Telephone +81-86-235-6712
E-mail t-maru@md.okayama-u.ac.jp
Affiliation Okayama University Hospital